Next-generation automated insulin delivery algorithm raises time in range in diabetes

morningstar.com·Jun 6, 2026 · 10 h fa

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

morningstar.com·Jun 4, 2026 · 2 g fa

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

morningstar.com·Jun 6, 2026 · 22 h fa

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

morningstar.com·Jun 6, 2026 · 8 h fa

Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

statnews.com·Jun 6, 2026 · 15 min fa

Triple hormone receptors, a monthly obesity drug, and a bittersweet ending

morningstar.com·Jun 6, 2026 · 2 h fa

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

morningstar.com·Jun 6, 2026 · 2 h fa

82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

morningstar.com·Jun 2, 2026 · 4 g fa

The American Diabetes Association's Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease Management and Prevention

adnkronos.com·Jun 4, 2026 · 2 g fa

AGP & DTx Summit: Digital therapeutics show 0.54% HbA1c reduction as diabetes care moves from monitoring to change

dailymail.com·Jun 3, 2026 · 3 g fa

Daily tablet could transform type 2 diabetes treatment, trial finds